Your browser doesn't support javascript.
loading
Asymptomatic carriers of the p.A53T SNCA mutation: Data from the PPMI study.
Simitsi, Athina Maria; Koros, Christos; Stamelou, Maria; Beratis, Ion; Efthymiopoulou, Efthymia; Papadimitriou, Dimitra; Bougea, Anastasia; Picillo, Marina; Stanitsa, Evangelia; Papagiannakis, Nikolaos; Antonelou, Roubina; Pachi, Ioanna; Papageorgiou, Sokratis G; Barone, Paolo; Stefanis, Leonidas.
Afiliação
  • Simitsi AM; 1st Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Koros C; 1st Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Stamelou M; 1st Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece; Parkinson's Disease and Movement Disorders Department, HYGEIA Hospital, Athens, Greece; School of Medicine, European University of Cyprus, Nicosia, Cyprus; Neurology Clini
  • Beratis I; 1st Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Efthymiopoulou E; 1st Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Papadimitriou D; Neurology Clinic, Henry Dunan Hospital, Athens, Greece.
  • Bougea A; 1st Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Picillo M; Centre for Neurodegenerative Diseases, University of Salerno, Italy.
  • Stanitsa E; 1st Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Papagiannakis N; 1st Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Antonelou R; 1st Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Pachi I; 1st Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Papageorgiou SG; 1st Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Barone P; Centre for Neurodegenerative Diseases, University of Salerno, Italy.
  • Stefanis L; 1st Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece; Biomedical Research Foundation, Academy of Athens (BRFAA), Athens, Greece. Electronic address: lstefanis@bioacademy.gr.
Parkinsonism Relat Disord ; 98: 72-74, 2022 05.
Article em En | MEDLINE | ID: mdl-35490542
ABSTRACT
We assessed non motor characteristics of 12 asymptomatic p.A53T mutation carriers (A53T-AC) compared with 36 healthy controls (HC) enrolled in the Parkinson's Progression Markers Initiative (PPMI) study. Olfaction score was lower and anxiety was marginally more prevalent in A53T- AC. These findings suggest distinct prodromal features in this group of subjects.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Alfa-Sinucleína / Sintomas Prodrômicos Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Alfa-Sinucleína / Sintomas Prodrômicos Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article